Published on 5 Jun 2023 on Simply Wall St. via Yahoo Finance
Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap touched US$481m last week, benefiting both...
Key Insights
Significant control over Repare Therapeutics by private equity firms implies that the general public has more power to influence management and governance-related decisionsA total of 6 investors have a majority stake in the company with 55% ownership Institutions own 28% of Repare Therapeutics
If you want to know who really controls Repare Therapeutics Inc. (NASDAQ:RPTX), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are private equity firms with 34% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).